Bortezomib and dexamethasone as first-line therapy for a patient with newly diagnosed polyneuropathy, organomegaly, endocrinopathy, M protein and skin changes syndrome complicated by renal failure

Leuk Lymphoma. 2012 Dec;53(12):2527-9. doi: 10.3109/10428194.2012.690515. Epub 2012 Jun 12.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Anti-Inflammatory Agents / therapeutic use
  • Antineoplastic Agents / therapeutic use
  • Boronic Acids / therapeutic use*
  • Bortezomib
  • Dexamethasone / therapeutic use*
  • Drug Therapy, Combination
  • Humans
  • Induction Chemotherapy / methods
  • Male
  • Middle Aged
  • POEMS Syndrome / complications
  • POEMS Syndrome / drug therapy*
  • Pyrazines / therapeutic use*
  • Renal Insufficiency / complications
  • Renal Insufficiency / drug therapy*
  • Treatment Outcome

Substances

  • Anti-Inflammatory Agents
  • Antineoplastic Agents
  • Boronic Acids
  • Pyrazines
  • Bortezomib
  • Dexamethasone